CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Allergan Inc. v. Barr Laboratories Inc.

1:09-cv-00333

Overview

Case Number 1:09-cv-00333
Filing Date 2009-05-07
Status Terminated
Termination Date 2011-09-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Both

Parties

Defendant

Teva Pharmaceutical Industries Ltd Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman & Spence, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman & Spence, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, Goldman & Spence, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman & Spence, P.A., 1200 North Broom Street

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

3 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Megan C. Haney

Phillips, Goldman & Spence, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman & Spence, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, Goldman & Spence, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman & Spence, P.A., 1200 North Broom Street

Plaintiff

Allergan Inc. Operating Company

Represented By

4 Attorneys Listed

William J. Marsden , Jr.

Fish & Richardson, P.C.

Tel: +1 (302) 652-5070
Fax: +1 (302) 652-0607

222 Delaware Avenue, 17th Floor, P.O. Box 1114

Douglas Edward McCann

Fish & Richardson, P.C.

Tel: +1 (302) 652-5070
Fax: +1 (302) 652-0607

222 Delaware Avenue, 17th Floor, P.O. Box 1114

Jonathan E. Singer

Email: singer@fr.com

Jennifer Lynne Hall

U.S. Attorney's Office

Tel: +1 (302) 573-6277

The Nemours Building, 1007 Orange Street, Suite 700

Counter Claimant

Barr Laboratories Inc. Operating Company

Represented By

13 Attorneys Listed

George C. Lombardi

Email: glombardi@winston.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Lindsay M. Beyer

UNDELIVERABLE EMAIL 3/7/13

Eric L. Broxterman

Email: ebroxterman@fitcheven.com

Trang Hoang

Email: thoang@winston.com

Megan C. Haney

Phillips, Goldman & Spence, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman & Spence, P.A., 1200 North Broom Street

Ali Ahmed

Email: aahmed@winston.com

Michael K. Nutter

Email: mnutter@winston.com

John C. Phillips , Jr.

Phillips, Goldman & Spence, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman & Spence, P.A., 1200 North Broom Street

Bradley C. Graveline

UNDELIVERABLE EMAIL 4/24/14

Ryanne Easley

Email: reasley@winston.com

Kevin E. Warner

Email: KWarner@winston.com

Gina J. Oka

Email: goka@winston.com

Sandoz Inc. Operating Company

Represented By

2 Attorneys Listed

Richard William Riley

Duane Morris LLP

Tel: +1 (302) 657-4928

1100 North Market Street, Suite 1200

Brandon C. Helms

Email: bhelms@steptoe.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 18 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (18): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5688819
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Filed: 1996-02-22
Issued: 1997-11-18
Expired (Term Ended)
Expires: 2014-08-20
US6403649
Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Filed: 2000-03-06
Issued: 2002-06-11
Expired (Term Ended)
Expires: 2020-03-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

43

Dispositive

0

Granted

0

Denied

0

Pending / Review

43

Motions by Category

Procedural / Extension Motion 8 Motion to Compel Discovery 1 Claim Construction / Markman Filing 12 Motion to Strike / Sanctions 22

Key Dispositive Motions & Rulings

Motion to Strike / Sanctions Pending / Under Review
REPLY BRIEF re 229 MOTION to Strike 223 POST Trial Brief References to and Arguments Based upon Unadmitted Evidence filed by Allergan Inc.. (McCann, Douglas) (E...
Entry #233 • 2011-07-15 Document →
Motion to Strike / Sanctions Pending / Under Review
ANSWERING BRIEF in Opposition re 229 MOTION to Strike 223 POST Trial Brief References to and Arguments Based upon Unadmitted Evidence filed by Barr Laboratories...
Entry #231 • 2011-07-05 Document →
Motion to Strike / Sanctions Pending / Under Review
MOTION to Strike 223 POST Trial Brief References to and Arguments Based upon Unadmitted Evidence - filed by Allergan Inc.. (Attachments: # 1 Text of Proposed Or...
Entry #229 • 2011-06-15 Document →
Motion to Strike / Sanctions Pending / Under Review
OPENING BRIEF in Support re 229 MOTION to Strike 223 POST Trial Brief References to and Arguments Based upon Unadmitted Evidence filed by Allergan Inc..Answerin...
Entry #230 • 2011-06-15 Document →
Motion to Strike / Sanctions Pending / Under Review
SEALED REPLY BRIEF re 182 MOTION to Strike Opinions and Exclude Testimony of Plaintiff's Expert Timothy L. Macdonald, Ph.D., 186 MOTION to Strike Opinions and E...
Entry #201 • 2011-01-11 Document →
Motion to Strike / Sanctions Pending / Under Review
REPLY BRIEF re 178 MOTION to Strike 165 Declaration Plaintiff Allergan, Inc.'s Motion To Strike The Declaration of Douglass F. Taber, Ph.D. filed by Allergan In...
Entry #200 • 2011-01-06 Document →

Docket Entries

(259 total)
Pleading / Complaint

COMPLAINT with Exhibit A and Exhibit B filed with Jury Demand against Barr Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 157399.) - filed by Allergan Inc. (Attachments: # 1 Civil Cover Sheet, # 2 Acknowledgement of Consent Form)(dab) (Entered: 05/08/2009)

Entry #1 • 2009-05-07
1
Pleading / Complaint

COMPLAINT with Exhibit A and Exhibit B filed with Jury Demand against Barr Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 157399.) - filed by Allergan Inc. (Attachments: # 1 Civil Cover Sheet, # 2 Acknowledgement of Consent Form)(dab) (Entered: 05/08/2009)

Entry #1 • 2009-05-07
2
Pleading / Complaint

COMPLAINT with Exhibit A and Exhibit B filed with Jury Demand against Barr Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 157399.) - filed by Allergan Inc. (Attachments: # 1 Civil Cover Sheet, # 2 Acknowledgement of Consent Form)(dab) (Entered: 05/08/2009)

Entry #1 • 2009-05-07
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dab) (Entered: 05/08/2009)

Entry #2 • 2009-05-07
1

Disclosure Statement pursuant to Rule 7.1 filed by Allergan Inc. (dab) (Entered: 05/08/2009)

Entry #3 • 2009-05-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc